Fruzaqla

Fruzaqla is an oral medication containing fruquintinib, used for targeted therapy in certain cancer treatments. This prescription drug is designed to inhibit specific enzymes involved in tumor growth.

Fruzaqla is primarily used in the treatment of advanced colorectal cancer. It works by targeting and blocking enzymes that promote the growth of cancer cells. Patients typically use this medication as part of a broader treatment plan under medical supervision.

Common effects of Fruzaqla may include fatigue, diarrhea, and changes in blood pressure. Some users might experience nausea or vomiting. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

Fruzaqla should be handled with care, following the prescribed dosage and administration guidelines. It is essential to inform your healthcare provider about any pre-existing conditions or other medications you are taking to avoid potential complications.

Fruzaqla may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid grapefruit and grapefruit juice, as they can interfere with the drug's effectiveness. Always consult a healthcare provider before starting or stopping any medication.